Suivre
Ross W Ward
Ross W Ward
Autres nomsRoss William Ward
Postdoctoral Researcher, Icahn School of Medicine at Mount Sinai
Adresse e-mail validée de tcd.ie
Titre
Citée par
Citée par
Année
Mucosal vaccines—fortifying the frontiers
EC Lavelle, RW Ward
Nature Reviews Immunology 22 (4), 236-250, 2022
5582022
Non-canonical inflammasome activation mediates the adjuvanticity of nanoparticles
N Muñoz-Wolf, RW Ward, CH Hearnden, FA Sharp, J Geoghegan, ...
Cell Reports Medicine 4 (1), 2023
252023
Publisher Correction: Mucosal vaccines—fortifying the frontiers
EC Lavelle, RW Ward
Nature reviews. Immunology 22 (4), 266, 2021
162021
Myeloid cell–derived proteases produce a proinflammatory form of IL-37 that signals via IL-36 receptor engagement
GP Sullivan, P Davidovich, N Muñoz-Wolf, RW Ward, ...
Science Immunology 7 (78), eade5728, 2022
62022
Protocol for the development of mRNA lipid nanoparticle vaccines and analysis of immunization efficiency in mice
N Karekar, AR Cahn, J Morla-Folch, A Saffon, RW Ward, ...
STAR protocols 5 (2), 103087, 2024
12024
Intratumoral delivery of the chitin-derived C100 adjuvant promotes robust STING, IFNAR, and CD8+ T cell-dependent anti-tumor immunity
JL Turley, RW Ward, J Huete-Carrasco, N Muñoz-Wolf, K Roche, L Jin, ...
Cell Reports Medicine 5 (5), 2024
12024
Mitochondrial respiratory complex III sustains IL-10 production in activated macrophages and promotes tumor-mediated immune evasion
A Zotta, J Toller-Kawahisa, EM Palsson-McDermott, SM O’Carroll, ...
Science Advances 11 (4), eadq7307, 2025
2025
Immunotherapy for cancer
E Lavelle, J Turley, R Ward
US Patent App. 18/039,107, 2024
2024
Rational design of polymer‐based particulate vaccine adjuvants
J Huete‐Carrasco, RI Lynch, RW Ward, EC Lavelle
European Journal of Immunology 54 (2), 2350512, 2024
2024
F-02 Inflammasome activating nanoparticles promote protective anti-tumour CD8 (+) T cells
R Ward, N Munoz-Wolf, EC Lavelle
yEFIS 1st Symposium: Shaping the future of Immunology in Europe 52, 25-25, 2022
2022
O-01 Enhancing antigen cross-presentation and CD8 (+) T cell responses by adsorbing antigen to nanoparticles
J Huete-Carrasco, N Munoz-Wolf, RW Ward, EC Lavelle
yEFIS 1st Symposium: Shaping the future of Immunology in Europe 52, 4-4, 2022
2022
P-1013 A novel polymer-based STING activator with potent anti-tumour activity
JL Turley, R W Ward, M Andersson, EC Lavelle
6th European Congress of Immunology 51, 396-396, 2021
2021
P-0842 Small polymeric nanoparticles drive potent anti‐tumour immunity
R William Ward, N Munoz-Wolf, E C Lavelle
6th European Congress of Immunology 51, 1-448, 2021
2021
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–13